##common.search##
##search.searchResults##
-
POSTSTROKE COGNITIVE IMPAIRMENT AND DEMENTIA. TREATMENT OF COGNITIVE IMPAIRMENT
Assessment of the effectiveness of the Citicoline which is used for treatment cognitive disfunction of poststroke patients
Results. In order to study the prevalence and severity of cognitive function among 114 postroke patients were examined using special methods to determine the severity of cognitive function. The results showed that 62.5% of these patients have clinical and neurological signs of cognitive disfunction, and 45% of them of them the phenomena of moderate severity and 25% of mild degree and 12% of severe degree. The type of cognitive impairment varied from the location of the lesion of the cerebral vessels. The use of Elfunat for the purpose of treatment in the early period of stroke improved cognitive function in patients.